The breast cancer specimen showed significant P53 protein overexpression, a common immunohistochemical surrogate for TP53 mutation, while the pancreatic adenocarcinoma unequivocally exhibited a mutant-type pattern of P53 expression. This evidence concerns the gene TP53 and breast cancer.